Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 4/2001

01-05-2001

Association of Family History and Other risk factors with Breast Cancer Risk among Japanese Premenopausal and Postmenopausal Women

Authors: Kaoru Hirose, Kazuo Tajima, Nobuyuki Hamajima, Toshiro Takezaki, Manami Inoue, Tetsuo Kuroishi, Shigeto Miura, Shinkan Tokudome

Published in: Cancer Causes & Control | Issue 4/2001

Login to get access
Metadata
Title
Association of Family History and Other risk factors with Breast Cancer Risk among Japanese Premenopausal and Postmenopausal Women
Authors
Kaoru Hirose
Kazuo Tajima
Nobuyuki Hamajima
Toshiro Takezaki
Manami Inoue
Tetsuo Kuroishi
Shigeto Miura
Shinkan Tokudome
Publication date
01-05-2001
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 4/2001
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1011232602348

Other articles of this Issue 4/2001

Cancer Causes & Control 4/2001 Go to the issue

OriginalPaper

Elevated Serum Homocysteine levels and Increased risk of Invasive Cervical Cancer in US Women

OriginalPaper

Pet Ownership and Childhood Acute Leukemia (USA and Canada)

Note

Tobacco Litigation: A Mid-Course Review

OriginalPaper

Smoking and Hematolymphopoietic Malignancies

OriginalPaper

A Pooled Analysis of Case–Control Studies of Thyroid Cancer. VI. Fish and Shellfish Consumption

OriginalPaper

Occupational Exposure to Diesel Engine Emissions and Risk of Cancer in Swedish Men and Women
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits